Aishworiya, R.; Chi, M.-H.; Zafarullah, M.; Mendoza, G.; Ponzini, M.D.; Kim, K.; Biag, H.M.B.; Thurman, A.J.; Abbeduto, L.; Hessl, D.;
et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells 2023, 12, 1920.
https://doi.org/10.3390/cells12141920
AMA Style
Aishworiya R, Chi M-H, Zafarullah M, Mendoza G, Ponzini MD, Kim K, Biag HMB, Thurman AJ, Abbeduto L, Hessl D,
et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells. 2023; 12(14):1920.
https://doi.org/10.3390/cells12141920
Chicago/Turabian Style
Aishworiya, Ramkumar, Mei-Hung Chi, Marwa Zafarullah, Guadalupe Mendoza, Matthew Dominic Ponzini, Kyoungmi Kim, Hazel Maridith Barlahan Biag, Angela John Thurman, Leonard Abbeduto, David Hessl,
and et al. 2023. "Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome" Cells 12, no. 14: 1920.
https://doi.org/10.3390/cells12141920
APA Style
Aishworiya, R., Chi, M. -H., Zafarullah, M., Mendoza, G., Ponzini, M. D., Kim, K., Biag, H. M. B., Thurman, A. J., Abbeduto, L., Hessl, D., Randol, J. L., Bolduc, F. V., Jacquemont, S., Lippé, S., Hagerman, P., Hagerman, R., Schneider, A., & Tassone, F.
(2023). Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells, 12(14), 1920.
https://doi.org/10.3390/cells12141920